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Key points:   
Concern for the safety to the fetus is a commonly cited reason for vaccine refusal during 
pregnancy. Results from this investigation support the safety of seasonal influenza 
vaccination during pregnancy and suggest seasonal influenza vaccination may be protective 
against stillbirth.  
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Abstract 1 
Background 2 
Although antenatal influenza vaccination is an important public health intervention for 3 
preventing serious infection in pregnant women and newborns, reported vaccine coverage is 4 
often below 50%. Concern for the safety to the fetus is a commonly cited reason for vaccine 5 
hesitancy and refusal. The incidence of stillbirth following pandemic vaccination has been 6 
previously studied; however no population-based study has evaluated the incidence of 7 
stillbirth following seasonal trivalent influenza vaccine (TIV). 8 
Methods 9 
We used probabilistic linking of perinatal and maternal vaccination records to establish a 10 
cohort of 58,008 births occurring between April 2012 and December 2013. Stillbirth was 11 
defined as birth ≥20 weeks gestation with an Apgar score of zero at one and five minutes 12 
following delivery. Cox regression models adjusted for maternal smoking, Indigenous status 13 
and propensity of vaccination were used to calculate adjusted hazard ratios (aHR) in 14 
vaccinated and unvaccinated mothers. 15 
Results 16 
A total of 5,076 (8.8%) pregnant women received TIV and 377 stillbirths occurred. There were 17 
5.0 and 3.0 stillbirths per 100,000 pregnancy days among unvaccinated and vaccinated 18 
women, respectively. After adjustment, stillbirth was 51% less likely among vaccinated vs 19 
unvaccinated mothers (aHR, 0.49; 95% confidence interval [CI], 0.29 to 0.84). The largest 20 
relative reduction in stillbirths was observed for births occurring just after influenza season 21 
(aHR, 0.33; 95% CI, 0.12 to 0.88).  22 
Conclusions 23 
Mothers who received seasonal TIV during pregnancy were significantly less likely to 24 
experience stillbirth compared with unvaccinated mothers. These results support the safety of 25 
seasonal influenza immunisation during pregnancy and suggest a protective effect.  26 
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Background 27 
Pregnant women are at increased risk of serious complications following influenza infection, 28 
including pneumonia and acute respiratory distress syndrome.1–3 This increased risk is 29 
thought to be the result of depressed cell-mediated immunity and physiological changes to the 30 
cardiopulmonary system associated with pregnancy.1,3 Influenza infection during pregnancy 31 
has also been linked to adverse fetal and neonatal outcomes, including increased risk of 32 
preterm birth1,4 and fetal mortality; this effect has been most pronounced during influenza 33 
pandemics.2,5,6 During the recent 2009 influenza A/H1N1 pandemic, a significant increase in 34 
perinatal mortality was observed following maternal infection, most of this attributable to a 35 
four-fold increase in stillbirths.5,7 36 
 37 
Seasonal influenza vaccination has been shown to prevent infection in mothers and their 38 
newborn infants,8,9 and the World Health Organization has indicated that pregnant women 39 
should receive the highest priority for seasonal influenza vaccination.10 Reported vaccine 40 
uptake remains below 50% in pregnant women, and concern regarding the safety of the 41 
vaccine for the fetus is a commonly cited reason why women refuse vaccination.11–12 42 
Enhanced data collection and surveillance during the 2009 H1N1 pandemic offered the unique 43 
opportunity to monitor the safety of pandemic influenza vaccination in large, observational 44 
studies.13 These studies suggested stillbirth was less common in women who received 45 
pandemic vaccine compared to unvaccinated women, supporting the safety of pandemic 46 
influenza vaccination during pregnancy;5,13–16 however, to date, no population-based study 47 
has been conducted to evaluate the impact of antenatal administration of seasonal influenza 48 
vaccination on stillbirth during non-pandemic influenza seasons.13,16 The aim of this study was 49 
to assess the relative risk of stillbirth among vaccinated and unvaccinated pregnant women 50 
during the 2012 and 2013 seasonal influenza epidemics in the winter months of the southern 51 
hemisphere. 52 
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Methods 53 
Western Australia has a population of 2.4 million people, with 71% residing in the Perth 54 
metropolitan area. There are approximately 30,000 births each year. For this analysis, multiple 55 
state-wide data sources were linked by the Western Australian Data Linkage Branch of the 56 
Western Australia Department of Health, using probabilistic matching of the full name and date 57 
of birth of mothers who delivered in Western Australia between 1 April 2012 and 31 December 58 
2013. The project was approved by the Western Australia Department of Health Human 59 
Research Ethics Committee. 60 
Data sources 61 
Vaccination status 62 
Seasonal trivalent influenza vaccine has been provided at no cost under the National 63 
Immunisation Program to pregnant women since 2009 and has been part of routine antenatal 64 
care in Western Australia since 2012. Post-partum surveys estimate that 25-36% of women 65 
who were pregnant during the study period received seasonal trivalent influenza vaccine.17 66 
The majority of pregnant women in Australia receive their influenza vaccine from general 67 
practitioners; an additional 19% are immunised at public hospital antenatal clinics.17 As part 68 
of ongoing vaccine safety surveillance, providers administering influenza vaccine during 69 
pregnancy under the National Immunisation Program are asked to inform the Western 70 
Australia Department of Health of the name, date of birth, and vaccination date of the 71 
expectant mother. This information is stored in the Western Australia Antenatal Influenza 72 
Vaccination Database. In our cohort, women with a vaccination record in the database with a 73 
date of influenza vaccination occurring between the estimated date of conception (based on 74 
gestation) and 14 days prior to date of delivery were defined as vaccinated during pregnancy. 75 
 76 
 77 
Birth information 78 
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The Midwives Notification System is a legally mandated data collection system which requires 79 
the healthcare professional attending the birth to provide information at the time of delivery 80 
related to the pregnancy for all births in Western Australia ≥20 weeks gestation.18 The midwife 81 
in attendance usually submits birth information to the system; however, in the absence of a 82 
midwife the medical officer is asked to submit the information. If there is no midwife or medical 83 
officer in attendance, the first qualified midwife or medical offer to attend would submit the 84 
information. In Western Australia, 98% of births occur in hospital (59% of which are public), 85 
and 1% occur at a birth centre, all of which are staffed by midwives.18 The remaining 1% of 86 
births occur at home, which may or may not be attended by a midwife. The Midwives 87 
Notification System is thought to include 99% of births in the state.19 Midwives Notification 88 
System data include the date of birth, birth weight, postcode of residence, status of the baby 89 
at birth (alive or dead), Apgar scores at one and five minutes after delivery, medical conditions 90 
of the mother, and complications related to the pregnancy and delivery. Gestation provided in 91 
Midwives Notification System data is estimated based on a previously validated algorithm 92 
drawing from both antenatal indicators (e.g. expected due date) and neonatal indicators of 93 
gestation (e.g. sole creases, scalp hair).20 Stillbirth was defined as a birth where the infant was 94 
recorded as stillborn by the clinician and had an Apgar score of zero at one minute and five 95 
minutes following birth. This definition is consistent with previously published definitions.21 96 
Maternal characteristics 97 
Maternal age, pre-existing medical conditions, the occurrence of medical complications during 98 
pregnancy (including pre-eclampsia, gestational diabetes, threatened abortion, threatened 99 
preterm labour and urinary tract infections), and smoking during pregnancy (yes/no) were 100 
obtained from the midwives’ records. Indigenous status was defined using a previously 101 
validated algorithm drawing from multiple government administrative data sets.22 The 102 
statistical local area of the mother at the time of birth was used to calculate a Socio-Economic 103 
Indexes for Areas (SEIFA) score. Statistical local areas are Australian Standard Government 104 
Classification defined local areas which cover the whole of Australia. SEIFA is comprised of 105 
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several indices, the main index being that of relative disadvantage which is derived from low 106 
income, low educational attainment, high unemployment and jobs in unskilled 107 
occupations.23 SEIFA scores were grouped into quintiles. Statistical local areas were also used 108 
to assign individuals into levels of remoteness of their residence based on the Accessibility 109 
and Remoteness Index (ARIA) scale, a national index developed by the National Centre for 110 
Social Applications of Geographic Information Systems. ARIA scores are based on road 111 
distance measurements from the statistical local area of residence to the nearest populated 112 
locality greater than 1,000 persons; scores range from one (highly accessible) to five (highly 113 
remote).24 114 
Statistical analysis 115 
The odds of vaccination and stillbirth were compared by maternal characteristics using 116 
binomial logistic regression models. The odds of stillbirth were also compared by influenza 117 
virus circulation at three time periods: pre-influenza season, influenza season, and post-118 
influenza season. Pre-influenza season was defined as 1 Apr - 3 Jun 2012 and 1 Jan - 14 Jul 119 
2013; influenza season was defined as 4 Jun - 23 Sep 2012 and 15 Jul -13 Oct 2013; and 120 
post-influenza season was defined as 24 Sep - 31 Dec 2012 and 14 Oct - 31 Dec 2013 (Figure 121 
1). Seasonal cut-points were determined based on state-wide notifications for laboratory-122 
confirmed influenza during 2012 and 2013.  123 
 124 
Similar to previous investigations,5,25–26 we used Cox regression models to compare the risk 125 
of stillbirth in vaccinated and unvaccinated women. Days of gestation from 20 weeks was 126 
included as the underlying time variable and vaccination status as the time-dependent 127 
exposure variable. Because 62% of vaccinated women were immunised after 20 weeks of 128 
pregnancy, i.e. during the observation period, vaccinated women contributed unvaccinated 129 
person-time until their date of vaccination. Because influenza vaccine uptake was more 130 
common in our cohort in women with higher risk pregnancies,17,21 models were adjusted by 131 
propensity of vaccination to avoid potential confounding by indication. Propensity scores for 132 
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vaccination were derived from a logistic regression model with maternal age, SEIFA and ARIA 133 
scores, primiparity, multiple births, pre-existing medical conditions, and complications of 134 
pregnancy as independent variables and vaccination status as the dependent variable. 135 
Propensity scores ranged from -0.68 to 1.07 (median: 0.23, IQR: 0.05, 0.44). Models were 136 
also adjusted for Indigenous status of the mother and self-reported smoking during pregnancy. 137 
 138 
To estimate the effect in births following influenza season compared to the effect in births prior 139 
to influenza season, we calculated a ratio of hazard ratios using the approach outlined by 140 
Altman and Bland.27 Hazards regression models were also created to compare the risk of 141 
stillbirth in preterm pregnancies (<37 weeks) and full-term pregnancies (≥37 weeks), and for 142 
five levels of propensity for vaccination (strata 1, -0.69-0.01; strata 2, 0.02-0.15; strata 3, 0.16-143 
0.30; strata 4, 0.31-0.50; strata 5, 0.51-1.07). All covariates were tested to determine whether 144 
models met the assumption of proportional hazards (α=.05).  145 
Results 146 
A total of 59,333 midwives records were provided for linkage with a date of birth from 1 April 147 
2012 to 31 December 2013. Of these, 1,325 were excluded because the mother resided 148 
outside of Western Australia (n=71) or had missing covariate information (n=1,254), leaving 149 
58,008 births for analysis.  A total of 5,541 births were linked to an influenza vaccination record 150 
of which 5,076 (92%) had a date of administration 14 days or more prior to the date of delivery. 151 
Therefore, the final dataset included 58,008 births, 5,076 to vaccinated mothers and 52,932 152 
to unvaccinated mothers (Figure 2), contributing 7,716,084 days of follow-up during pregnancy 153 
(462,808 days vaccinated and 7,253,276 days unvaccinated). The majority of births included 154 
in the analysis were to mothers who were <35 years of age (80%), non-Indigenous (94%), and 155 
in the top 20% socioeconomic (SEIFA) level (65%); 44% resided in a metropolitan area.  156 
Influenza vaccination 157 
Stillbirth and seasonal influenza vaccination during pregnancy, 7 
 
Overall, 8.7% of the cohort received seasonal influenza vaccine during their pregnancy (6.9% 158 
in 2012% and 10.2% in 2013). The proportion of births to vaccinated mothers ranged from 159 
0.5% in April 2012 to 15.8% in August 2013, with the number of doses administered to 160 
pregnant women peaking in April each year (Figure 1); 18.7% of vaccinated mothers were 161 
immunised in the first 13 weeks of pregnancy; 45.7% were immunised in weeks 14 to 27 of 162 
their pregnancy; and 35.6% were immunised in week 28 or later of pregnancy. Vaccination 163 
was more common among women >35 years of age (odds ratio [OR], 1.08; 95% confidence 164 
interval [CI], 1.01 to 1.15), women residing in highly accessible areas (OR, 2.17; 95% CI, 1.86 165 
to 2.54), and women in the highest socioeconomic level (OR, 1.25; 95% CI, 1.09 to 1.45). 166 
Women with pre-existing medical conditions were more likely to receive an influenza vaccine 167 
(OR, 1.46; 95% CI, 1.38 to 1.54), as were women with pre-eclampsia (OR, 1.32; 95% CI, 1.11 168 
to 1.57) or gestational diabetes (OR, 1.34; 95% CI, 1.21 to 1.48). Primiparous women and 169 
women with multiple births were also more likely to be vaccinated compared to multiparous 170 
and women with a singleton pregnancy (OR, 1.14; 95% CI, 1.07 to 1.21 and OR, 1.35; 95% 171 
CI, 1.15 to 1.58, respectively) (Table 1). 172 
Stillbirth 173 
During the observation period, 377 stillbirths occurred, equating to 6.5 per 1,000 births overall. 174 
Stillbirth was more common among women with diabetes (OR, 2.93; 95% CI, 1.44 to 5.93) or 175 
hypertension (OR, 1.92; 95% CI, 1.92 to 5.88), women who smoked during pregnancy (OR, 176 
1.42; 95% CI, 1.07 to 1.89), and Indigenous women (OR, 2.04; 95% CI, 1.47 to 2.83) (Table 177 
2). Stillbirth was less common among women in the highest socioeconomic level (OR, 0.66; 178 
95% CI, 0.44 to 0.99) and women residing in highly accessible areas (OR, 0.66; 95% CI, 0.46 179 
to 0.97). Women with a multiple pregnancy had four times the odds of stillbirth compared to 180 
women with a singleton pregnancy (OR, 4.08; 95% CI, 2.89 to 5.75). The majority (66.4%) of 181 
stillbirths in the cohort occurred between 20 and 27 weeks gestation. Although not statistically 182 
significant, stillbirth was more common during post-influenza season compared with pre-183 
influenza season (p=0.07) (Table 2).  184 
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 185 
The unadjusted incidence of stillbirth in unvaccinated mothers was 5.0 per 100,000 pregnancy 186 
days compared with 3.0 per 100,000 pregnancy days in vaccinated women (Table 3). The 187 
adjusted risk of stillbirth was 51% lower among vaccinated women compared to unvaccinated 188 
women (adjusted hazard ratio (aHR), 0.49; 95% CI, 0.29 to 0.84).  Of the 465 women who 189 
were vaccinated <14 days before the date of delivery, i.e. classified as unvaccinated for this 190 
analysis, none had a stillbirth.  When comparing the rate of stillbirth by gestational age, a 191 
significant reduction in stillbirths among vaccinated mothers was only observed for stillbirths 192 
occurring prior to 37 weeks of gestation (aHR, 0.45; 95% CI, 0.26 to 0.81). There was a non-193 
significant reduction in stillbirth associated with maternal influenza vaccination prior to the start 194 
of the influenza season (aHR, 0.60; 95% CI, 0.22 to 1.61) and during the influenza season 195 
(aHR, 0.57; 95% CI, 0.25 to 1.31); however, a greater and significant reduction was observed 196 
for births occurring during the post-influenza season period (aHR, 0.33; 95% CI, 0.12 to 0.88) 197 
(Figure 3). The ratio of hazards ratios during the post-influenza season period compared to 198 
the pre-influenza season period was 0.55 (95% CI, 0.13 to 2.49), suggesting the effect of 199 
vaccination may be greater following influenza season.   200 
Discussion 201 
To our knowledge, this is the first population-based study of seasonal trivalent influenza 202 
vaccine and stillbirth, and the largest cohort study to date evaluating maternal vaccination and 203 
stillbirth. We observed a reduced hazard of stillbirth associated with seasonal trivalent 204 
influenza vaccine administered during pregnancy after controlling for risk factors for stillbirth 205 
and accounting for factors associated with disproportionate uptake of maternal vaccination. 206 
These results are consistent with those of previous large cohort studies investigating the 207 
perinatal impact of pandemic and monovalent influenza vaccination in pregnancy13–16,26 and 208 
support the safety of antenatal administration of seasonal trivalent influenza vaccine.  209 
 210 
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Several findings in our study support an association between influenza infection and stillbirth. 211 
The observed rate of stillbirth was higher following periods of influenza virus circulation (e.g. 212 
November through December) compared to periods prior to influenza season (e.g. January 213 
through May).  Although seasonal differences were not statistically significant (p=0.07), these 214 
results suggest a possible temporal association between stillbirth and influenza season. 215 
Researchers in Finland observed seasonal patterns in the population incidence of stillbirth, 216 
with the highest rates of stillbirth occurring just after influenza season in the northern 217 
hemisphere (March) and the lowest rates in summer and autumn.28 Furthermore, the effect 218 
estimate between vaccination and stillbirth was greater during the post-influenza season 219 
period compared to the pre-influenza season period. Additional studies should further evaluate 220 
the possible temporal association between stillbirth and influenza season. 221 
 222 
Our results are consistent with those of previous large cohort studies of maternal influenza 223 
vaccination during an influenza pandemic.13–15,26 Although observational cohort studies, such 224 
as ours, are subject to potential bias, including uncontrolled confounding due to the nature of 225 
the study design,13 there are several strengths to this large observational cohort study. First, 226 
observational cohort studies are the most efficient method of measuring the impact of maternal 227 
influenza vaccination on stillbirth, given the relatively low incidence of stillbirth in developed 228 
countries and potentially low uptake of vaccine.13 With an incidence of 6.4 stillbirths per 1,000 229 
births in Australia,29 other study designs such as randomised controlled trials would be 230 
implausible, as well as unethical, given that maternal influenza vaccination is now 231 
recommended as standard of care. Second, previous observational, cohort studies have taken 232 
measures to prevent uncontrolled confounding, including propensity score adjustment26 and 233 
controlling for known maternal risk factors,15 and have observed a significant protective effect 234 
of maternal vaccination. Similar to these investigations, we stratified our analyses by the 235 
mother’s propensity for vaccination and adjusted for known maternal risk factors for stillbirth. 236 
Regardless of maternal risk factors and differing predisposition to vaccination, stillbirth was 237 
significantly less common in vaccinated mothers compared to unvaccinated.   238 
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 239 
Despite the strengths of this cohort study, there are several limitations to our cohort which 240 
should be considered. Measurement of vaccination status in this cohort is thought to have 241 
been incomplete. In the absence of a registry of adult vaccinations in Australia, we relied on 242 
provider-reported vaccination events and there was no legal requirement to report these 243 
vaccinations. An evaluation of the completeness of reporting for maternal influenza 244 
vaccinations in Western Australia found that approximately half (46%) get reported to the state 245 
vaccination database.30 In addition, a post-partum survey of mothers in Western Australia who 246 
delivered in April through October in 2012 and 2013 indicated that 26% and 36% (respectively) 247 
had received an influenza vaccination during the study period.17 In our cohort, 9% and 14% of 248 
mothers were reportedly immunised during these respective time periods. However, because 249 
false positives (i.e. reporting a vaccination when one did not occur) are very unlikely in the 250 
vaccination database,30 exposure misclassification in our cohort would likely bias our results 251 
toward the null, indicating the protective effect between vaccinations and stillbirths that we 252 
observed may be an underestimate of the true effect measure. Second, our cohort was 253 
restricted to the Australian setting over two influenza seasons; therefore our results may not 254 
be generalizable to developing countries, where stillbirth is more common, or influenza 255 
seasons for which the protection afforded by the vaccine might be different. Finally, due to low 256 
number of outcomes in our dataset, we were unable to compare the safety of seasonal 257 
influenza vaccine by trimester of administration. Future research should examine whether the 258 
lower incidence of stillbirth associated with antenatal influenza vaccinations we observed is 259 
applicable to other influenza seasons and settings and across trimesters of vaccine 260 
administration. 261 
Conclusions 262 
Our results support the safety of maternal influenza vaccination, as we found no increase in 263 
the risk of stillbirth in vaccinated women. Additional research is needed to confirm the potential 264 
reduction in stillbirth observed in this cohort study. There are over three million stillborn infants 265 
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each year worldwide, and in developed countries stillbirth accounts for 70% of perinatal 266 
deaths;31 confirmation of these findings would indicate seasonal influenza vaccination in 267 
pregnancy has substantial perinatal health benefits. These results may be useful for 268 
communicating the potential benefits of seasonal influenza vaccination to pregnant mothers 269 
and their providers. Given the growing body of evidence supporting the health benefits to 270 
mother and infant, concerted efforts are needed to improve seasonal influenza vaccine 271 
coverage among pregnant women.  272 
Stillbirth and seasonal influenza vaccination during pregnancy, 12 
 
Author Contributions 
AR performed all data management and analysis and led the writing of the manuscript; NK, 
HM, SO, and PE each contributed to the study design, interpretation of data, and writing of 
the manuscript.  GS and DM contributed to the study design and writing of the manuscript. 
 
Acknowledgements 
The authors would like to thank the Linkage and Client Services Teams at the Western 
Australian Data Linkage Branch, in particular Alexandra Godfrey and Mikhalina 
Dombrovskaya, as well as the Data Custodians Maureen Hutchinson (Midwives Notification 
System) and Robyn Gibbs (Western Australia Antenatal Influenza Vaccination Database). 
Additional thanks are given to Dr Gary Dowse, Data Custodian for the Western Australia 
Notifiable Infectious Diseases Database, who provided laboratory-confirmed influenza data 
for the purposes of assessing seasonal influenza activity. One of the authors, Dr Geoffrey 
Shellam, passed away during the preparation of this manuscript. The co-authors are 
especially grateful for Dr Shellam’s contributions to the research design, analysis and initial 
drafting of the manuscript. This work was conducted as part of an evaluation of a state 
vaccination program and was funded by the Communicable Disease Control Directorate, 
Western Australia Department of Health. AR, NK, SO, PE, DM, and GS has no alternative 
sources of funding to disclose; HM was supported by an Early Career Fellowship of the 
National Health and Medical Research Council (APP1034254). AR, HM, NK, SO, PE, GS, 
and DM have no potential conflicts of interest to disclose. 
 
 
  
Stillbirth and seasonal influenza vaccination during pregnancy, 13 
 
Table 1. Antenatal influenza vaccination status of women who delivered in 
Western Australia between 1 April 2012 and 31 December 2013, by 
demographic characteristics and obstetric history.* 
 
Characteristic 
 
Percent vaccinated 
 
Vaccinated versus 
Unvaccinated 
Maternal age  n % (95% CI) OR (95% CI)* 
     <35 years 3,987 8.6 (8.4-8.9) Ref 
     ≥35 years 1,089 9.2 (8.7-9.8) 1.08 (1.01-1.15) † 
Indigenous status    
    Indigenous 317 9.6 (8.7-10.7) Ref 
    Non-Indigenous 4,759 8.7 (8.5-8.9) 0.89 (0.79-1.01) 
Socioeconomic status (SEIFA)    
    Quintile 1 (most disadvantaged) 227 7.1 (6.2-8.0) Ref 
    Quintile 2  754 8.1 (7.6-8.7) 1.16 (0.99-1.35) 
    Quintile 3 612 7.7 (7.2-8.3) 1.10 (0.94-1.29) 
    Quintile 4 1,701 9.9 (9.5-10.3) 1.44 (1.25-1.66) † 
    Quintile 5 (least disadvantaged) 1,782 8.7 (8.3-9.1) 1.25 (1.09-1.45) † 
Remoteness of residence (ARIA)    
    Very remote 177 4.9 (4.2-5.7) Ref 
    Remote 126 8.0 (6.8-9.5) 1.69 (1.33-2.14)‡ 
    Moderately accessible 357 7.4 (6.7-8.2) 1.55 (1.29-1.87) ‡ 
    Accessible 1,855 8.2 (7.8-8.6) 1.73 (1.48-2.03 ‡ 
    Highly accessible 2,561 10.1 (9.7-10.5) 2.17 (1.86-2.54)‡ 
Pre-existing diabetes    
     No 5,014 8.7 (8.5-8.9) Ref 
     Yes 62 14.3 (11.4-18.0) 1.76 (1.34-2.30)‡ 
Essential hypertension    
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*Shown are the odds of vaccination by select demographic and medical characteristics of mothers as calculated by 
unconditional logistic regression models. 
†Significant at α=.05 
‡Significant at α=.01 
§ Complications during pregnancy included pre-eclampsia, gestational diabetes, threatened preterm abortion, threatened 
preterm labour, and urinary tract infections.
     No 5,005 8.7 (8.5-8.9) Ref 
     Yes 71 11.5 (9.2-14.2) 1.36 (1.06-1.74)‡ 
Asthma    
     No 4,477 8.6 (8.4-8.8) Ref 
     Yes 599 10.1 (9.4-10.9) 1.20 (1.10-1.31)‡ 
Smoked during pregnancy    
     No 4,520 8.8 (8.5-9.0) Ref 
     Yes 556 8.6 (7.9-9.3) 0.98 (0.89-1.07) 
Complications during pregnancy§    
     No 4,087 8.4 (8.2-8.7) Ref 
     Yes 989 10.5 (9.9-11.2) 1.29 (1.19-1.38)‡ 
Type of delivery    
     Singleton 4,902 8.7 (8.5-8.9) Ref 
     Multiple 174 11.3 (9.8-13.0) 1.35 (1.15-1.58) ‡ 
Parity    
     Multiparous 3,352 8.4 (8.2-8.7) Ref 
     Primiparous 1,724 9.5 (9.0-9.9) 1.14 (1.07-1.21) ‡ 
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Table 2. Stillbirths recorded in Western Australia between 1 April 2012 and 
31 December 2013, by maternal characteristics.* 
 
Characteristic 
 
Stillbirths per 1,000 pregnancies 
 
Stillbirth vs live 
birth 
Maternal age  n No. per 1,000 (95% CI) OR (95% CI)* 
     <35 years 295 6.4 (5.7-7.2) Ref 
     ≥35 years 82 6.9 (5.5-8.6) 1.09 (0.85-1.39) 
Indigenous status    
    Indigenous 41 12.5 (9.0-16.9) Ref 
    Non-Indigenous 336 6.1 (5.5-6.8) 2.04 (1.47-2.83)† 
Socioeconomic status (SEIFA)    
    Quintile 1 (most disadvantaged) 29 9.1 (6.3-13.0) Ref 
    Quintile 2  64 6.9 (5.4-8.8) 0.76 (0.49-1.18) 
    Quintile 3 49 6.2 (4.7-8.2) 0.68 (0.43-1.08) 
    Quintile 4 112 6.5 (5.4-7.8) 0.72 (0.48-1.08) 
    Quintile 5 (least disadvantaged) 123 6.0 (5.0-7.2) 0.66 (0.44-0.99) † 
Remoteness of residence (ARIA)    
    Very remote 34 9.4 (6.8-13.1) Ref 
    Remote 13 8.3 (4.8-14.1) 0.88 (0.46-1.67) 
    Moderately accessible 28 5.8 (4.0-8.4) 0.62 (0.37-1.02)  
    Accessible 142 6.3 (5.3-7.4) 0.66 (0.45-0.97)‡ 
    Highly accessible 160 6.3 (5.4-7.4) 0.66 (0.46-0.97)‡ 
Pre-existing diabetes    
     No 369 6.4 (5.8-7.1) Ref 
     Yes 8 18.5 (9.4-36.1) 2.93 (1.44-5.93) ‡ 
Essential hypertension    
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     No 364 6.3 (5.7-7.0) Ref 
     Yes 13 21.0 (12.3-35.6) 3.36 (1.92-5.88) ‡ 
Asthma    
     No 344 6.6 (5.9-7.3) Ref 
     Yes 33 5.6 (4.0-7.8) 0.85 (0.59-1.21) 
Smoked during pregnancy    
     No 320 6.2 (5.6-6.9) Ref 
     Yes 57 8.8 (6.8-11.4) 1.42 (1.07-1.89) ‡ 
Complications during pregnancy    
     No 308 6.3 (5.7-7.1) Ref 
     Yes 69 7.4 (5.8-9.3) 1.16 (0.90-1.51) 
Type of delivery    
     Singleton 340 6.0 (5.4-6.7) Ref 
     Multiple 37 24.1 (17.5-33.1) 4.08 (2.89-5.75)‡ 
Parity    
     Multiparous 257 6.5 (5.7-7.3) Ref 
     Primiparous 120 6.6 (5.5-7.9) 1.02 (0.82-1.27) 
Influenza season    
     Pre-season 147 6.2 (5.2-7.2) Ref 
     Within season 111 6.1 (5.0-7.3) 0.99 (0.77-1.26) 
     Post-season 119 7.5 (6.3-9.0) 1.22 (0.95-1.55) 
*Shown are the odds of stillbirth by select demographic and medical characteristics of mothers as calculated by unconditional 
logistic regression models. 
†Significant at α=.05 
‡Significant at α=.01 
§ Complications during pregnancy included pre-eclampsia, gestational diabetes, threatened preterm abortion, threatened 
preterm labour, and urinary tract infections.
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Table 3. Hazard ratio of stillbirth, by maternal influenza vaccination status* 
*Listed are the incidence and hazard of stillbirth compared by seasonal influenza vaccination status in mothers as 
calculated based on Cox regression models.  
† Adjusted analyses controlled for maternal smoking, Indigenous status, and propensity for vaccination. 
§Significant at α=.01 
¶Significant at α=.05 
§§ Propensity scores were calculated based on maternal age, SEIFA and ARIA score, primiparity, multiple birth, pre-
existing medical conditions, and complications of pregnancy as in Table 1. 
  
 Vaccinated 
(n=5,076) 
Unvaccinated 
(n=52,932) 
Hazard Ratio (95% CI)* 
 Stillbirths per 
100,000 
pregnancy days 
Stillbirths per 
100,000 
pregnancy days 
Unadjusted  Adjusted†  
TOTAL 3.0 5.0 0.52 (0.31-0.91)§ 0.49 (0.29-0.84)§ 
By gestation 
    at <37 weeks 32.8 67.8 0.43 (0.24-0.77)§ 0.45 (0.26-0.81)§ 
    at ≥37 weeks 0.5 0.6 1.20 (0.29-4.97) 1.13 (0.27-4.71) 
By propensity for influenza vaccination§§ 
    -0.69-0.01 1.6 3.4 0.39 (0.05-2.79) 0.36 (0.05-2.60) 
    0.02-0.15  3.7 4.6 0.72 (0.23-2.29) 0.68 (0.21-2.18) 
    0.16-0.30  3.5 4.1 0.74 (0.23-2.38) 0.74 (0.23-2.38) 
    0.31-0.50 2.9 6.3 0.41 (0.13-1.30) 0.41 (0.13-1.29) 
    0.51-1.07 3.2 6.7 0.41 (0.15-1.13) 0.40 (0.15-1.10) 
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Figure 1. Weekly distribution of live and stillbirths, doses of seasonal 
trivalent influenza vaccine and laboratory-confirmed influenza cases 
during cohort study period. 
 
Figure 2. Data linkage of birth cohort – Western Australia, Australia, 2012-
13. 
 
Figure 3. Hazard ratio of stillbirth, by seasonal influenza activity* 
Figure 3 footnotes: 
*Depicted are the hazard ratios of stillbirth in mothers who had trivalent influenza 
vaccination compare to unvaccinated mother during pre-influenza, influenza, and 
post-influenza periods as calculated based on Cox regression models.  
 
†Hazard ratios were calculated using Cox regression models which adjusted for maternal smoking, 
Indigenous status, and propensity for vaccination. 
 
§ Influenza season was defined based on state-wide laboratory-confirmed influenza notifications. Pre-
influenza season included births occurring between 01Apr2012-03Jun2012 and 01Jan2013-
14Jul2013, influenza season included births occurring between 04Jun2012-23Sep2012 and 
15Jul2013-13Oct2013, and post-influenza season included births occurring between 24Sep2012-
31Dec2012 and 14Oct2013-31Dec2013. 
 
¶ Significant at α=.01. 
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